Direct comparison of a simple blood test processed with the Parsortix system with invasive solid biopsy of the metastatic site delivers comprehensive gene expression analysis Leading US cancer center, the University of Southern California Norris Comprehensive Cancer Center presents data ...
Read More »Parsortix selected by the European consortium to validate blood-based biomarkers for cancer
ANGLE plc, the specialist medtech company, is pleased to announce that it has been formally selected for CANCER-ID, the European consortium to validate blood-based biomarkers for cancer. CANCER-ID is a European consortium funded by the Innovative Medicines Initiative (IMI), with ...
Read More »